Post-Translational Methylation of Human Rad52 in Response to Dna Damage and Replication Stress
J. W. Wray,J. Liu,M. Shaheen,R. Hromas,J. A. Nickoloff,Z. Shen
DOI: https://doi.org/10.1016/j.ijrobp.2014.05.619
2014-01-01
Abstract:Homologous recombination (HR) is important for DNA double-strand break (DSB) repair and replication fork restart. Mammalian RAD52 retains RAD51 binding and single-strand DNA annealing activities and is involved in oxidative damage repair, which causes replication stress. Yeast RAD52 is essential in HR, but studies have shown that mammalian BRCA2 has supplanted RAD52 in mediating RAD51 function. Recent studies have shown that defects in RAD52 and BRCA2 are synthetically lethal, indicating a redundant role in repair. To further define human RAD52, we set out to identify and characterize post-translational modifications of RAD52. We found that RAD52 can be methylated in response to ionizing radiation (IR) and hydroxyurea (HU), and mutation of lysine-116 to arginine prohibits this modification. We hypothesized that methylation would regulate human RAD52 functions and dynamics in response to replication stress. Site-specific mutagenesis was employed to create the RAD52-K116R mutant. Wild-type RAD52 and RAD52-K116R were tagged with HA, Myc, or enhanced green fluorescent protein (EGFP) and stably expressed in HT-1080 cells for all experiments. Cells were mock treated or treated with 8 Gy of IR or 10 mM of HU, incubated for 6 hours, and then subjected to immunoprecipitation (IP), Western blot (WB), and scoring of nuclear EGFP-RAD52 foci. For protein stability, cells were incubated with cycloheximide, and protein levels were quantified by WB. To measure protein mobility, EGFP-RAD52 expressing cells were live imaged for fluorescence recovery after photobleaching analysis 6-8 hours after treatments. Cell survival fractions were determined by colony formation assay after varying doses of IR or HU. Using IP of Myc-RAD52 followed by WB with an antibody against methylated lysine, we found that RAD52 is methylated in response to DNA damage. Mutation of RAD52-K116 to arginine (K116R) reduces methylation, destabilizes RAD52, and reduces focus formation and diffusion rate changes in response to HU. Finally, RAD52-K116R overexpression has a dominant negative effect on cell survival after HU but not IR. Previously, we found that replication stress induces RAD52 co-localization with RAD51, and RAD52 has reduced diffusion consistent with enhanced oligomerization and association with chromatin. This suggests that RAD52 has a role in the response to replication fork arrest. Our results indicate that RAD52 lysine-116 contributes to RAD52 methylation, which regulates RAD52 stability and function in response to replication stress. Since RAD52 is synthetically lethal with BRCA2, this modification may present a novel druggable target to destabilize RAD52 in BRCA2-deficient cancers, conferring synthetic lethality and therapeutic gain similar to that observed with PARP inhibitors.